TrialESMO open2024

Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.

C Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.